These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6264079)

  • 1. Calcium metabolism in bone disease: effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol.
    Dent CE; Davies IJ
    J R Soc Med; 1980 Nov; 73(11):780-5. PubMed ID: 6264079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis.
    Stellon A; Davies A; Webb A; Williams R
    Postgrad Med J; 1985 Sep; 61(719):791-6. PubMed ID: 2997764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcitonin and phosphate metabolism. Analysis of active calcium and phosphorus in children treated with Calcitar].
    Vulović D; Stojanov Lj; Nedeljković V; Banicević M; Zamurović D
    Srp Arh Celok Lek; 1977 Nov; 105(11):967-74. PubMed ID: 617001
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of oral administration of calcium carbonate, aluminum hydroxide gel and dihydrotachysterol on renal acidosis.
    Ueda H; Ikeda H; Sasaki Y; Shioji R
    Tohoku J Exp Med; 1978 Jan; 124(1):1-11. PubMed ID: 635890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of zoledronate in adult patients with osteogenesis imperfecta. An observational Spanish study with five years of follow-up.
    Pavón de Paz I; Rosado Sierra JA; Pérez Blanco C; Modroño Móstoles N; Guijarro de Armas G; Navea Aguilera C
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):108-116. PubMed ID: 30077631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dihydrotachysterol (DHT) on calcium metabolism in uremia.
    Asad S; Ellis K; Cohn S; Letter J
    Trans Am Soc Artif Intern Organs; 1974; 20A():142-7. PubMed ID: 4450332
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peri-osteocytic calcium fixation under calcitonin treatment. Microradiographic study using automatic analysis of images in 8 cases of osteogenesis imperfecta].
    Duriez J; Flautre B
    Nouv Presse Med; 1975 Jan; 04(2):97-100. PubMed ID: 1138231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early effects of dihydrotachysterol on calcium and phosphorus metabolism in patients with hypoparathyroidism.
    Hunt G; Morgan DB
    Clin Sci; 1970 Jun; 38(6):713-25. PubMed ID: 5431603
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of A.T. 10 on calcium and phosphorus metabolism in resistant rickets.
    SAVILLE PD; NASSIM JR; STEVENSON FH; MULLIGAN L; CAREY M
    Clin Sci; 1955 Aug; 14(3):489-99. PubMed ID: 13250771
    [No Abstract]   [Full Text] [Related]  

  • 10. Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study.
    Otaify GA; Aglan MS; Ibrahim MM; Elnashar M; El Banna RA; Temtamy SA
    Osteoporos Int; 2016 Jan; 27(1):81-92. PubMed ID: 26138583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alendronate treatment in children with osteogenesis imperfecta.
    Akcay T; Turan S; Guran T; Bereket A
    Indian Pediatr; 2008 Feb; 45(2):105-9. PubMed ID: 18310788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of stable isotopic tracers in studies of whole body calcium metabolism.
    Yergey AL; Vieira NE; Abrams SA; Marini J; Goans RE
    Connect Tissue Res; 1995; 31(4):291-3. PubMed ID: 15612371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of renal osteodystrophy in children with dihydrotachysterol and 24,25-dihydroxyvitamin D3.
    van Diemen-Steenvoorde R; Donckerwolcke RA; Bosch R; Visser WJ; Raymakers JA; Duursma SA
    Clin Nephrol; 1985 Dec; 24(6):292-9. PubMed ID: 3878249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of synthetic salmon calcitonin in osteogenesis imperfecta.
    Castells S; Lu C; Baker RK; Wallach S
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):1-14. PubMed ID: 4203843
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypercalcaemia due to dihydrotachysterol treatment in patients with hypothyroidism after thyroidectomy.
    Lamberg BA; Tikkanen MJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6289):461-2. PubMed ID: 6790016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
    Palomo T; Fassier F; Ouellet J; Sato A; Montpetit K; Glorieux FH; Rauch F
    J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of patients with osteogenesis imperfecta.
    Albright JA; Grunt JA
    J Bone Joint Surg Am; 1971 Oct; 53(7):1415-25. PubMed ID: 5114704
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.
    Land C; Rauch F; Travers R; Glorieux FH
    Bone; 2007 Mar; 40(3):638-44. PubMed ID: 17127117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.
    Blouin S; Fratzl-Zelman N; Glorieux FH; Roschger P; Klaushofer K; Marini JC; Rauch F
    J Bone Miner Res; 2017 Sep; 32(9):1884-1892. PubMed ID: 28548288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective calcium absorption in the proximal small intestine in chronic renal failure: effect of dihydrotachysterol.
    Coen G; Segni MD; Stirati G; Cinotti GA
    J Urol Nephrol (Paris); 1976; 82(4-5):339-43. PubMed ID: 940179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.